Holding
Novo NordiskNVO
GLP-1 drugs (Ozempic/Wegovy) linked to dementia reduction and cardiovascular longevity.
weight · 8.00%·sector · Healthcare·exchange · NYSE
GLP-1 drugs (Ozempic/Wegovy) linked to dementia reduction and cardiovascular longevity.